Prostate Cancer Lab #54: What Should I Do about My Neuroendocrine Cancer? (Amit Gattani)
“If there is something related to neuroendocrine control, that is what is of most interest.” – Amit Gattani Meeting Summary Some advanced cancer patients find
“If there is something related to neuroendocrine control, that is what is of most interest.” – Amit Gattani Meeting Summary Some advanced cancer patients find
“You’re going about the exercise portion in the context of everything else that’s going on.” – Dr. Tom Incledon “When I look at all the
“The medical oncologist and the radiation oncologist were really against the PSMA. They were transparent, and said they thought he would be high volume based
“Be honest with yourself, and be honest with your providers about symptoms you’re having. If a bone hurts, please tell somebody about it. If you’re
Brian McCloskey has advanced prostate cancer. He’s been through the standard of care. but his cancer is resisting the treatments. Read about the problem he’s
CancerHacker Lab contributes to a Prostate & Urological Health campaign led by Future of Personal Health. Read the article written by Brad Power here: Advanced
Meeting Summary Advanced prostate cancer patients Brian McCloskey and Rick Stanton introduced themselves, their medical history, and their objectives for the Prostate Cancer Lab. Brian
Categories
Archives
Recent Posts
Adaptive Therapy advanced cancer navigator AI/ML Amit Gattani Bob Gatenby boost immune system Brad Power Brian McCloskey Bryce Olson cancer vaccines complementary therapy Curematch Emma Shtivelman Eric Hall exercise Exercise as medicine Filtricine Functional Testing Glenn Sabin Guest Podcast Hackathons for Patients John Chant Karin Rodland Kasey Altman Kerri Winters-Stone Massive Bio Mike Yancey Mina Nikanjam Modeling NCCN nutrition palliative care Patient Cases Payel Chatterjee Personalized Treatment Proteomics Rick Stanton RNA Sequencing Robert Ellis Saed Sayad Strategy Tom Smith Tony Letai Treatment Matching Treatment Options
© 2021 CancerHacker Lab. All rights reserved
Recent Comments